** = Publikationen gelistet in SCI/SSCI/Pubmed
** Cejka, V; Riepl, H; Schwegel, N; Kolesnik, E; Zach, D; Santner, V; Höller, V; Schweighofer, N; Obermayer-Pietsch, B; Pieber, T; Morbach, C; Frantz, S; Zirlik, A; von, Lewinski, D; Störk, S; Posch, F; Ablasser, K; Verheyen, N
Prognostic impact of gait speed, muscle strength and muscle mass in chronic heart failure-A prospective cohort study.
ESC Heart Fail. 2025; 12(3):2113-2124
Doi: 10.1002/ehf2.15221
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Debonnaire, P; Dujardin, K; Verheyen, N; Pouleur, AC; Droogmans, S; Claeys, M; Bohyn, A; Bogaerts, K; El, Haddad, M; Christiaen, E; Wyseure, N; Zach, DK; Buytaert, L; Jacobs, A; Buysschaert, I; Trenson, S; Van, Hoeyweghen, R; Tavernier, R
Tafamidis in octogenarians with wild-type transthyretin cardiac amyloidosis: an international cohort study.
Eur Heart J. 2025;
Doi: 10.1093/eurheartj/ehae923
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schwegel, N; Toferer, C; Zach, DK; Santner, V; Höller, V; Lugitsch, J; Wallner, M; Gollmer, J; Aziz, F; von, Lewinski, D; Kolesnik, E; Ablasser, K; Zirlik, A; Sourij, H; Verheyen, N
Impact of SGLT2-Inhibitor Therapy on Survival in Patients with Transthyretin Amyloid Cardiomyopathy: Analysis of a Prospective Registry Study.
J Clin Med. 2024; 13(19):
Doi: 10.3390/jcm13195966
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schwegel, N; Zach, D; Peikert, A; Santner, V; Höller, V; Gollmer, J; Späth, J; Riepl, H; Rainer, PP; Wallner, M; Pilz, S; Zirlik, A; von, Lewinski, D; Ablasser, K; Verheyen, N; Kolesnik, E
The Prognostic Value of Right Ventricular Function in Patients with Chronic Heart Failure-A Prospective Study.
J Clin Med. 2024; 13(7): 1930
Doi: 10.3390/jcm13071930
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Auer, J; Bonaros, N; Buchacher, T; Dalos, D; Grimm, M; Mayr, A; Rab, A; Reinstadler, S; Scherr, D; Toth, GG; Weber, T; Zach, DK; Zaruba, MM; Zimpfer, D; Rainer, PP; Pölzl, G
Austrian consensus statement on the diagnosis and management of hypertrophic cardiomyopathy.
Wien Klin Wochenschr. 2024; 136(Suppl 15): 571-597.
Doi: 10.1007/s00508-024-02442-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Schmid, J; Kolesnik, E; Schwegel, N; Späth, J; Kattnig, L; Riepl, H; Zach, D; Santner, V; Höller, V; Pilz, S; Tomaschitz, A; Fuchsjäger, M; Fahrleitner-Pammer, A; Dimai, HP; Obermayer-Pietsch, B; Fruhwald, F; Scherr, D; Zirlik, A; von, Lewinski, D; Ablasser, K
Prevalence and prognostic impact of bone disease in chronic heart failure with reduced ejection fraction.
ESC Heart Fail. 2024; 11(3):1730-1738
Doi: 10.1002/ehf2.14741
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zach, DK; Schwegel, N; Santner, V; Winkelbauer, L; Hoeller, V; Kolesnik, E; Gollmer, J; Seggewiss, H; Batzner, A; Perl, S; Wallner, M; Reiter, U; Rainer, PP; Zirlik, A; Ablasser, K; Verheyen, N
Low-grade systemic inflammation and left ventricular dysfunction in hypertensive compared to non-hypertensive hypertrophic cardiomyopathy.
Int J Cardiol. 2024; 399:131661
Doi: 10.1016/j.ijcard.2023.131661
Web of Science
PubMed
FullText
FullText_MUG
** Debonnaire, P; Dujardin, K; Verheyen, N; Pouleur, AC; Droogmans, S; Claeys, M; El Haddad, M; Christiaen, E; Zach, D; Buytaert, L; Jacobs, A; Buysschaert, I; Trenson, S; Van Hoeyweghen, R; Tavernier, R
AI-enabled cardiac chambers volumetry in non-contrast coronary artery calcium CT scans vs. contrast-enhanced coronary CT angiography scans in the same patients
EUR HEART J. 2024; 45: ehae666206
Doi: 10.1093/eurheartj/ehae666.206
[Poster]
Web of Science
FullText
FullText_MUG
** Schwegel, N; Santner, ; Zach, DK; Hoeller, ; Wallner, M; Muendlein, A; Brandtner, EM; Leiherer, A; Drexel, H; Mader, A; Von Lewinski, D; Ablasser, K; Kolesnik, E; Zirlik, A; Verheyen, N
Prognostic value of circulating glypican-4 in patients with chronic heart failure with reduced ejection fraction
EUR HEART J. 2024; 45(S1):ehae666971--ESC Congress; AUG 30-SEP 02, 2024; London, UK.
Doi: 10.1093/eurheartj/ehae666.971
[Poster]
Web of Science
FullText
FullText_MUG
** Toferer, C; Schwegel, N; Santner, ; Zach, DK; Hoeller, ; Wallner, M; Gollmer, J; Aziz, F; Von Lewinski, D; Kolesnik, E; Ablasser, K; Zirlik, A; Sourij, H; Verheyen, N
Prognostic impact of SGLT2-inhibitor therapy on survival in patients with transthyretin amyloid cardiomyopathy
EUR HEART J. 2024; 45(S1):ehae6662037--ESC Congress; AUG 30-SEP 02, 2024; London, UK.
Doi: 10.1093/eurheartj/ehae666.2037
[Poster]
Web of Science
FullText
FullText_MUG
** Winkelbauer, L; Santner, ; Schwegel, N; Hoeller, ; Gollmer, J; Kolesnik, E; Wallner, M; Von Lewinski, D; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D
Left atrial reservoir strain differentiates cardiac amyloidosis and hypertrophic cardiomyopathy
EUR HEART J. 2024; 45(S1):ehae666946--ESC Congress; AUG 30-SEP 02, 2024; London, UK.
Doi: 10.1093/eurheartj/ehae666.946
[Poster]
Web of Science
FullText
FullText_MUG
** Zach, DK; Batzner, A; Schwegel, N; Santner, ; Hoeller, ; Ablasser, K; Morbach, C; Stoerk, S; Maack, C; Reiter, U; Rainer, PP; Frantz, S; Zirlik, A; Seggewiss, H; Verheyen, N
Residual mitral leaflet length independently indicates left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
EUR HEART J. 2024; 45: ehae666098
Doi: 10.1093/eurheartj/ehae666.098
[Poster]
Web of Science
FullText
FullText_MUG
** Santner, V; Riepl, HS; Posch, F; Wallner, M; Rainer, PP; Ablasser, K; Kolesnik, E; Hoeller, V; Zach, D; Schwegel, N; Kreuzer, P; Lueger, A; Petutschnigg, J; Pieske, B; Zirlik, A; Edelmann, F; Verheyen, N
Non-eligibility for pivotal HFpEF/HFmrEF outcome trials and mortality in a contemporary heart failure cohort.
Eur J Intern Med. 2023; 118:73-81
Doi: 10.1016/j.ejim.2023.07.027
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Batzner, A; Zach, D; Zirlik, A; Gerull, B; Frantz, S; Maack, C; Störk, S; Seggewiss, H; Morbach, C
Spatial relationship between mitral valve and ventricular septum assessed by resting echocardiography to diagnose left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
Eur Heart J Cardiovasc Imaging. 2023; 24(6): 710-718.
Doi: 10.1093/ehjci/jead036
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lugitsch, J; Hoeller, V; Schwegel, N; Santner, V; Gollmer, J; Kolesnik, E; Lipp, R; Niedrist, T; Rainer, P; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D
Interleukin-6 plasma levels predict mortality and heart failure events in cardiac transthyretin amyloidosis
EUR HEART J. 2023; 44: -Annual Meeting of the European-Society-of-Cardiology (ESC); AUG 25-28, 2023; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
** Lugitsch, J; Holler, V; Schwegel, N; Santner, V; Gollmer, J; Kolesnik, E; Lipp, R; Niedrist, T; Rainer, P; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D
Interleukin-6 plasma levels predict mortality and heart failure events in cardiac transthyretin amyloidosis
WIEN KLIN WOCHENSCHR. 2023; 135: S472-S473.
[Poster]
Web of Science
FullText
** Schwegel, N; Riepl, H; Spath, J; Kolesnik, E; Zach, D; Santner, V; Holler, V; Obermayer-Pietsch, B; Schmid, J; Scherr, D; von Lewinski, D; Zirlik, A; Ablasser, K; Verheyen, N
Role of Comorbidities in Chronic Heart Failure-a prospective cohort study
WIEN KLIN WOCHENSCHR. 2023; 135: S477-S477.
Web of Science
FullText
** Zach, D; Schwegel, N; Hoeller, V; Kolesnik, E; Gollmer, J; Reiter, U; Seggewiss, H; Batzner, A; Zirlik, A; Rainer, P; Ablasser, K; Verheyen, N
Comparing indices of systemic inflammation and cardiac phenotype between hypertensive and non-hypertensive hypertrophic cardiomyopathy
EUR HEART J. 2023; 44: -Annual Meeting of the European-Society-of-Cardiology (ESC); AUG 25-28, 2023; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
** Zach, D; Schwegel, N; Holler, V; Kolesnik, E; Gollmer, J; Reiter, U; Seggewiss, H; Batzner, A; Zirlik, A; Rainer, P; Ablasser, K; Verheyen, N
Comparing indices of systemic inflammation and cardiac phenotype in hypertensive and non-hypertensive hypertrophic cardiomyopathy
WIEN KLIN WOCHENSCHR. 2023; 135: S475-S476.
[Poster]
Web of Science
FullText
** Verheyen, N; Ungericht, M; Paar, L; Danninger, K; Schneiderbauer-Porod, S; Duca, F; Cherouny, B; Hoeller, V; Ablasser, K; Zach, D; Kolesnik, E; Kiblboeck, D; Frick, M; Bonderman, D; Dierneder, J; Ebner, C; Weber, T; Pölzl, G
Diagnostic Accuracy of Bone Scintigraphy for the Histopathological Diagnosis of Cardiac Transthyretin Amyloidosis-A Retrospective Austrian Multicenter Study.
Biomedicines. 2022; 10(12):
Doi: 10.3390/biomedicines10123052
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Grubler, M; Zach, D; Holler, V; Seebacher, HA; Verheyen, N
A rare genetic cause of left ventricular hypertrophy and heart failure with preserved ejection fraction
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 2):129-129.
[Poster]
Web of Science
** Verheyen, N; Batzner, A; Zach, D; Gerull, B; Frantz, S; Maack, C; Stork, S; Seggewiss, H; Morbach, C
Quantification of systolic anterior motion of the mitral valve to identify left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 2): 102-103.
[Poster]
Web of Science
** Verheyen, N; Batzner, A; Zach, D; Zirlik, A; Gerull, B; Stoerk, S; Maack, C; Seggewiss, H; Morbach, C
Quantification of systolic anterior motion of the mitral valve to predict left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy
EUR HEART J. 2022; 43: 158-158.
Web of Science
** Verheyen, N; Ungericht, M; Paar, L; Danninger, K; Schneiderbauer-Porod, S; Duca, F; Cherouney, B; Holler, V; Ablasser, K; Zach, D; Kiblbock, D; Frick, M; Bonderman, D; Dierneder, J; Ebner, C; Weber, T; Polzl, G
Diagnostic accuracy of amyloid scintigraphy for the histopathological diagnosis of cardiac transthyretin amyloidosis-a retrospective Austrian multicenter study
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 2): 89-90.
[Poster]
Web of Science
** Höller, V; Seebacher, H; Zach, D; Schwegel, N; Ablasser, K; Kolesnik, E; Gollmer, J; Waltl, G; Rainer, PP; Verheyen, S; Zirlik, A; Verheyen, N
Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy-The Graz Hypertrophic Cardiomyopathy Registry.
Genes (Basel). 2021; 12(10):
Doi: 10.3390/genes12101469
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zach, D; Ablasser, K; Kolesnik, E; Hoeller, V; Fruhwald, F; Prüller, F; Reiter, C; Beham-Schmid, C; Lipp, R; Rainer, PP; Zirlik, A; Wölfler, A; Verheyen, N
Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio.
ESC Heart Fail. 2021; 8(4):3397-3402
Doi: 10.1002/ehf2.13381
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Holler, V; Zach, D; Kolesnik, E; Wallner, M; Fruhwald, F; Rainer, P; Zirlik, A; Verheyen, N
Proportions and temporal trends of diseases leading to a hypertrophic cardiomyopathy phenotype. a prospective single-center cohort study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 3):S98-S98.
[Onlinepräsentation]
Web of Science
** Hoheneder, T; Ablasser, K; Zach, D; Kolesnik, E; Binder, J; Scherr, D; Fruhwald, F; Zirlik, A; von Lewinski, D; Verheyen, N
Echocardiographic right ventricular function assessment in patients with chronic heart failure-comparison between TAPSE and myocardial deformation analysis.
WIEN KLIN WOCHENSCHR. 2020; 132: S200-S201.
[Poster]
Web of Science
FullText
** Zach, D; Ablasser, K; Kolesnik, E; Fruhwald, F; Pruller, F; Reiter, C; Beham-Schmid, C; Lipp, R; Zirlik, A; Wolfler, A; Verheyen, N
Massive cardiac AL amyloidosis in the absence of monoclonal gammopathy.
WIEN KLIN WOCHENSCHR. 2020; 132: S237-S237.
[Poster]
Web of Science
FullText
** Zach, D; Ablasser, K; Kolesnik, E; Fruhwald, F; Pruller, F; Reiter, C; Beham-Schmid, C; Lipp, R; Zirlik, A; Wolfler, A; Verheyen, N
The exceptional Case of massive cardiac AL-Amyloidosis with missing monoclonal Gammopathy.
WIEN KLIN WOCHENSCHR. Abstracts 51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):73-73.-51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Nicolas, V; Seggewiss, H; Ablasser, K; Kolesnik, E; Zach, D; Binder, J; Zirlik, A; Toth, G
Alcohol septal ablation in a patient with hypertrophic obstructive cardiomyopathy due to Anderson-Fabry disease
WIEN KLIN WOCHENSCHR. 2019; 131: 292-292.
[Poster]
Web of Science
** Verheyen, NN; Seggewiss, H; Ablasser, K; Kolesnik, E; Zach, D; Binder, J; Zirlik, A; Toth, GG
Alcohol septal ablation in a patient with hypertrophic obstructive cardiomyopathy due to Anderson-Fabry disease
EUR J HEART FAIL. Abstracts of the Heart Failure 2019 and the World Congress on Acute Heart Failure, 25–28 May 2019, Megaron Athens International Conference Centre, Greece. 2019; 21(S1):344-344.-Heart Failure 2019 and the World Congress on Acute Heart Failure; MAY 25-28, 2019; Athens, Greece.
[Poster]
Web of Science